INCYTE CORP (INCY) vs PFIZER INC (PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | INCY | PFE |
|---|---|---|
| Sector | Industrials | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $5.14B | $62.58B |
| Revenue growth (YoY) | ▲ 21.2% | ▼ 1.6% |
| Net income | $1.29B | $7.77B |
| Gross margin | 92.8% | 74.3% |
| Diluted EPS | $6.41 | $1.36 |
| Insider net (6 mo) | +131.3K sh • 15 sells • 0 buys | +109.6K sh • 2 sells • 3 buys |
| Institutional owners | 44 | 43 |
| Institutional value held | $12.27B | $61.91B |
| Next earnings (est.) | Oct 27, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About INCYTE CORP (INCY)
Incyte is a global biopharmaceutical company headquartered in Wilmington, Delaware, with additional operations in Morges, Switzerland; Tokyo, Japan; and Montreal, Canada, focused on the discovery, development, and commercialization of proprietary therapeutics… Read more →
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across… Read more →
Source: SEC EDGAR.